You are here: Industry Insights > GAD

News List

LivFul and Global Access Diagnostics announce partnership for COVID-19 test kit distribution prnasia
June 09, 2021
LivFul and Global Access Diagnostics (GAD) today announced a new partnership to make a variety of diagnostic kits, starting with COVID-19 rapid antigen tests, available in Low to Middle Income Countries.
Vaccine slows loss of insulin production in type 1 diabetes genetic subgroup europeanpharmaceuticalreview
June 03, 2021
In a Phase II trial, injecting GAD-alum into the lymph nodes of newly diagnosed type 1 diabetes patients with a genetic variant slowed insulin production degradation.
Many With History of Anxiety Report Complete Mental Health drugs
January 20, 2020
For persons with a previous diagnosis of generalized anxiety disorder (GAD), factors associated with being in complete mental health (CMH) include female gender, older age, being married, and reporting good to excellent physical health ...
Biohaven Enrolls First Patient in Phase 3 Troriluzole Trial americanpharmaceuticalreview
February 21, 2019
Biohaven has enrolled its first patient in a Phase 3 clinical trial assessing the efficacy and safety of troriluzole in generalized anxiety disorder (GAD).....
Gene Therapy Forms New Polysynaptic Pathways in Parkinson's drugs
November 29, 2018
For patients with Parkinson's disease (PD) undergoing gene therapy, new polysynaptic functional pathways develop in the brain, according to a study published in the Nov. 28 issue of Science Translational Medicine.